Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Choose Semaglutide (Wegovy) If: Best for people who: Want the longest safety track record (5 years) Have good insurance coverage for Wegovy specifically Prefer lowest discontinuation rate (6.9%) Are satisfied with 15% average weight loss Advantages: Most real-world data, proven track record since 2021 Disadvantages: Lowest efficacy (14.9%), highest cost ($1,349/month) Choose Tirzepatide (Zepbound) If: Best for people who: Want highest efficacy among available options (22.5%) Prefer best tolerability (31% nausea, lowest) Want better value (~$290/month cheaper) Want medication available today Advantages: Superior efficacy, best side effect profile, lower cost Disadvantages: Less long-term data than Semaglutide (3 years vs 5) Consider Waiting for Retatrutide If: Might make sense if you: Can wait until 2027-2028 without health consequences Want maximum weight loss (28.7%) Have tried both Semaglutide and Tirzepatide with insufficient results Have flexible health timeline Advantages: Highest efficacy (28.7%) Disadvantages: 2+ year wait, highest discontinuation (18.2%), no long-term data Realistic Recommendations For most people today: Choose Tirzepatide
Dihexa Dihexa is a peptide with beneficial nootropic properties
Over time, these effects help most people consume fewer calories and lose a meaningful amount of body weight
10.1038/s41580-020-0230-3 [DOI] [PubMed] [Google Scholar] Silva-Adaya D., Gonsebatt M
Cross-reactivity happens when your immune system reacts to a drug that is chemically similar to the drug you are allergic to
